Ductopenia related liver sarcoidosis

Table 2 Epidemiological, clinical features and outcome of reported cases with hepatic sarcoidosis and ductopenia

Ref.	Age (Year)/Sex/Race	Jaundice	Maximum ALP	Maximun AST	Clinical outcome
[4]	29/M/Black	Yes	10 X	1 X	Died 9 years after diagnosis
	31/M/Black	Yes	14 X	5 X	Died 11 years after diagnosis
	23/M/Black	Yes	30 X	13 X	Alive, portal hypertension
	20/M/Black	Yes	35 X	9 X	Died 10 years after first seen
	33/M/Black	Yes	30 X	6 X	Died 18 years after first seen
[20]	56/M/White	Yes	3 X	4 X	Alive, no symptoms
[21]	50/F/Black	Yes	6 X	2 X	Alive, portal hypertension
	46/M/Black	Yes	3 X	2 X	Alive, portal hypertension
[15]	-/M/	Yes	9 X	4 X	Alive, no symptoms
[22]	62/F/-	No	10 X	2 X	Alive, cirrhosis
[23]	38/F/White	Yes	12 X	3 X	Died 26 years after diagnosis
	40/M/-	Yes	10 X	4 X	Died 10 years after diagnosis
[5]	27/M/Black	Yes	10 X	3 X	Alive, portal hypertension
	28/M/Black	No	9 X	2 X	alive, disabled
	44/M/Black	No	7 X	2 X	Alive, well
	24/F/Black	Yes	7 X	1 X	Alive, well
[24]	52/M/Black	No	8 X	1 X	Died, 4 years after diagnosis
[25]	44/M/-	No	4 X	1, 5 X	Alive, cirrhosis
[26]	62/M/-	No	1, 8 X	ND	Died, 3 years after diagnosis
Present case	54/F/White	Yes	5 X	1 X	Alive, cirrhosis

X: Upper limit of normal; ND: Not done; Ref: Reference; AST: Aspartate aminotransferase; ALP: Alkaline phosphatase.